IFF Jan 2025 75.000 call
- PR Newswire
IFF Unveils Its Controlled Release Platform Featuring Its Innovation and Trailblazing Excipients
IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health, today announced a new controlled release platform for its portfolio of controlled release products including METHOCEL™, ETHOCEL™, and POLYOX™. Under the banner, "Timing is Everything," the platform provides comprehensive solutions for pharmaceutical therapies to benefit patients and highlights the importance of controlled release of active ingredients and improving patient compliance. Complete with educatio
- GuruFocus.com
Dodge & Cox Amplifies Stake in International Flavors & Fragrances, Signaling Strategic ...
Insight into Dodge & Cox (Trades, Portfolio)'s First Quarter 2024 Investment Moves and Strategic Decisions
- Zacks
Why International Flavors (IFF) International Revenue Trends Deserve Your Attention
Examine the evolution of International Flavors' (IFF) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
